• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无菌镊子前房减压可减轻玻璃体内注射时的眼压峰值。

Sterile Caliper Anterior Chamber Decompression Mitigates Intraocular Pressure Spikes in Intravitreal Injections.

作者信息

Mansoor Mahsaw, Ahmad Noor-Us-Sabah, Ahmed S Bilal, Tadros Samuel, Folk James, Abramoff Michael D

机构信息

Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA.

Iowa City Veterans Affairs Medical Center, Iowa City, IA, USA.

出版信息

Transl Vis Sci Technol. 2024 Dec 2;13(12):13. doi: 10.1167/tvst.13.12.13.

DOI:10.1167/tvst.13.12.13
PMID:39661378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11636662/
Abstract

PURPOSE

To investigate the efficacy of a novel approach using a sterile caliper for anterior chamber (AC) decompression in reducing post-intravitreal injection (IVI) intraocular pressure (IOP) spikes.

METHODS

A prospective interventional case series conducted at the Iowa City Veterans Affairs Medical Center (VAMC) with Institutional Review Board approval. Patients were randomized to receive conventional IVI or IVI with sterile caliper decompression. Fifty eyes from 47 patients underwent IVI for various retinal pathologies. Subjects were randomly assigned to the intervention or control arm. Two resident physician providers performed injections, with one applying sterile caliper decompression (intervention) and the other following the standard technique (control). Baseline and postinjection IOP were measured using Tonopen (Reichert, Depew, NY).

RESULTS

In both groups there was a significant IOP rise following IVI (P < 0.0001). There was no significant difference in baseline IOP between groups (P = 0.082), but postinjection IOP was significantly lower in the intervention group (23.52 ± 5.98 mm Hg) compared to the control group (44.08 ± 8.48 mm Hg). There were no patients with an IOP spike >25 mm Hg in the intervention arm. The technique was effective regardless of lens status.

CONCLUSIONS

Sterile caliper AC decompression significantly reduced post-IVI IOP spikes presenting an efficient and cost-effective alternative to previously proposed methods of IOP reduction. Further studies are warranted to validate these findings and explore broader applications in ophthalmic interventions.

TRANSLATIONAL RELEVANCE

The caliper decompression technique presents potential benefit in preventing short-term morbidity associated with IOP spikes after IVI and addressing long-term concerns in patients with pre-existing glaucoma.

摘要

目的

研究一种使用无菌卡尺进行前房(AC)减压的新方法在降低玻璃体内注射(IVI)后眼压(IOP)峰值方面的疗效。

方法

在爱荷华市退伍军人事务医疗中心(VAMC)进行的一项前瞻性干预病例系列研究,已获得机构审查委员会批准。患者被随机分为接受传统IVI或接受无菌卡尺减压的IVI。47例患者的50只眼因各种视网膜病变接受了IVI。受试者被随机分配到干预组或对照组。两名住院医师进行注射,一人应用无菌卡尺减压(干预),另一人采用标准技术(对照)。使用眼压笔(Reichert,Depew,纽约)测量基线眼压和注射后眼压。

结果

两组在IVI后眼压均显著升高(P < 0.0001)。两组之间的基线眼压无显著差异(P = 0.082),但干预组注射后的眼压(23.52 ± 5.98 mmHg)显著低于对照组(44.08 ± 8.48 mmHg)。干预组没有眼压峰值>25 mmHg的患者。无论晶状体状态如何,该技术均有效。

结论

无菌卡尺前房减压显著降低了IVI后的眼压峰值,是一种比先前提出的降低眼压方法更有效且具成本效益的替代方法。有必要进行进一步研究以验证这些发现,并探索其在眼科干预中的更广泛应用。

转化相关性

卡尺减压技术在预防IVI后眼压峰值相关的短期发病率以及解决既往存在青光眼患者的长期问题方面具有潜在益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/85e1bbfe9d52/tvst-13-12-13-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/bba20df58bf3/tvst-13-12-13-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/432ee7967107/tvst-13-12-13-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/85e1bbfe9d52/tvst-13-12-13-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/bba20df58bf3/tvst-13-12-13-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/432ee7967107/tvst-13-12-13-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a0/11636662/85e1bbfe9d52/tvst-13-12-13-f003.jpg

相似文献

1
Sterile Caliper Anterior Chamber Decompression Mitigates Intraocular Pressure Spikes in Intravitreal Injections.无菌镊子前房减压可减轻玻璃体内注射时的眼压峰值。
Transl Vis Sci Technol. 2024 Dec 2;13(12):13. doi: 10.1167/tvst.13.12.13.
2
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.用于预防激光小梁成形术后眼压暂时升高的围手术期药物。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2.
3
Prophylactic intraocular pressure lowering measures in anti-vascular endothelial growth factor therapy: A systematic review and meta-analysis.抗血管内皮生长因子治疗中的预防性眼压降低措施:系统评价和荟萃分析。
Surv Ophthalmol. 2023 May-Jun;68(3):425-445. doi: 10.1016/j.survophthal.2022.12.002. Epub 2022 Dec 15.
4
Anterior Segment Parameters are Associated With Intraocular Pressure Spikes Following Cataract Surgery in Glaucoma Patients.眼前节参数与青光眼患者白内障手术后的眼压峰值相关。
J Glaucoma. 2025 Aug 1;34(8):637-643. doi: 10.1097/IJG.0000000000002589. Epub 2025 May 9.
5
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.抗血管内皮生长因子用于控制青光眼手术中的伤口愈合
Cochrane Database Syst Rev. 2016 Jan 15;2016(1):CD009782. doi: 10.1002/14651858.CD009782.pub2.
6
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.抗血管内皮生长因子联合玻璃体内注射类固醇治疗糖尿病性黄斑水肿。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD011599. doi: 10.1002/14651858.CD011599.pub2.
7
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼。
Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4.
8
Contributing factors to short-term intraocular pressure elevation following intravitreal anti-VEGF injections.玻璃体内注射抗血管内皮生长因子药物后短期眼压升高的相关因素。
BMC Ophthalmol. 2025 May 7;25(1):281. doi: 10.1186/s12886-025-04111-x.
9
Device-modified trabeculectomy for glaucoma.用于青光眼的设备改良小梁切除术
Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010472. doi: 10.1002/14651858.CD010472.pub2.
10
Evaluation of intraocular pressure and mean ocular perfusion pressure changes following intravitreal anti-VEGF injections.玻璃体内注射抗血管内皮生长因子(VEGF)后眼压及平均眼灌注压变化的评估
Eur J Ophthalmol. 2025 Jul;35(4):1272-1279. doi: 10.1177/11206721251318773. Epub 2025 Feb 21.

本文引用的文献

1
Immediate effect of anti-VEGF injections on optic nerve head: Correlation between intraocular pressure and anatomical peripapillary changes.抗 VEGF 注射对视神经头的即时影响:眼压与视盘周围解剖结构变化的相关性。
Eur J Ophthalmol. 2024 Jul;34(4):1174-1182. doi: 10.1177/11206721231210749. Epub 2023 Oct 29.
2
Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections.玻璃体内注射抗VEGF药物后急性眼压升高相关的临床特征
Clin Ophthalmol. 2023 Jun 13;17:1683-1690. doi: 10.2147/OPTH.S414212. eCollection 2023.
3
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII).
量化玻璃体腔内注射负担:玻璃体腔内注射治疗生活影响的问卷调查评估(QUALITII)。
BMJ Open Ophthalmol. 2022 Dec;7(1). doi: 10.1136/bmjophth-2022-001188. Epub 2022 Dec 19.
4
Prophylactic intraocular pressure lowering measures in anti-vascular endothelial growth factor therapy: A systematic review and meta-analysis.抗血管内皮生长因子治疗中的预防性眼压降低措施:系统评价和荟萃分析。
Surv Ophthalmol. 2023 May-Jun;68(3):425-445. doi: 10.1016/j.survophthal.2022.12.002. Epub 2022 Dec 15.
5
Prophylactic effect of brinzolamide-brimonidine fixed combination on intraocular pressure spikes after intravitreal anti-VEGF injections.布林佐胺-溴莫尼定固定复方制剂对玻璃体内抗 VEGF 注射后眼压升高的预防作用。
Int Ophthalmol. 2021 Sep;41(9):3191-3198. doi: 10.1007/s10792-021-01885-z. Epub 2021 Jun 10.
6
Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations.眼内抗 VEGF 注射后眼压升高:短期和长期考虑。
J Glaucoma. 2021 Dec 1;30(12):1019-1026. doi: 10.1097/IJG.0000000000001894.
7
Real-world comparison between the Tonopen and Goldmann applanation tonometry in a university glaucoma clinic.在大学青光眼诊所中对眼压计的真实世界比较。
Int Ophthalmol. 2021 May;41(5):1815-1825. doi: 10.1007/s10792-021-01742-z. Epub 2021 Mar 2.
8
Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections.抗青光眼药物对玻璃体内注射贝伐单抗后短期眼压波动的影响。
Int Ophthalmol. 2021 Mar;41(3):1081-1090. doi: 10.1007/s10792-020-01667-z. Epub 2021 Jan 2.
9
Reduction of Intraocular Pressure Spikes Due to Intravitreal Bevacizumab Injections by Scleral Indentation with Cotton Swab or Digital Ocular Massage: Innovative Techniques Compared.通过棉拭子巩膜压陷或指压眼球按摩降低玻璃体内注射贝伐单抗引起的眼压峰值:创新技术比较
Clin Ophthalmol. 2020 Aug 27;14:2533-2541. doi: 10.2147/OPTH.S263474. eCollection 2020.
10
Tono-Pen versus Goldmann Applanation Tonometry: A Comparison of 898 Eyes.眼压笔与压平眼压计测量眼压的比较:898 只眼的比较。
Ophthalmol Glaucoma. 2019 Nov-Dec;2(6):435-439. doi: 10.1016/j.ogla.2019.07.004. Epub 2019 Jul 27.